Solazyme Lands $52,000,000 Series D Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9a65ff7b-2239-4f1b-8c94-5eb447c3df76&Preview=1 - Date
8/9/2010 - Company Name
Solazyme - Mailing Address
225 Gateway Blvd. South San Francisco, CA 94080 - Company Description
Solazyme is a biotechnology company devoted to harnessing the energy-harvesting machinery of photosynthetic microbes to produce valuable products. Exploiting microbial photosynthesis, a biochemical system benefiting from 2.5 billion years of evolutionary optimization yet brought to genomic light very recently, the Company utilizes proprietary genetic engineering methods to develop commercially relevant, sunlight-driven biochemical pathways. - Website
http://www.solazyme.com - Transaction Type
Venture Equity - Transaction Amount
$52,000,000 - Transaction Round
Series D - Proceeds Purposes
Proceeds purpose were not disclosed. - M&A Terms
- Venture Investor
Morgan Stanley Venture Partners - Venture Investor
Braemar Energy Ventures - Venture Investor
Lightspeed Venture Partners - Venture Investor
The Roda Group - Venture Investor
Harris & Harris Group - Venture Investor
VantagePoint Venture Partners - Venture Investor
Zygote Ventures - Venture Investor
Chevron Technology Ventures
